---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-023185"
form_type: "8-K"
ticker: "BDX"
cik: "0000010795"
company_name: "BECTON DICKINSON & CO"
filed_at: "2026-04-02T23:59:59+00:00"
generated_at: "2026-05-15T07:47:13.270137+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# BD files recast financials to reflect Feb 2026 spin-off of Biosciences & Diagnostics

## Summary
- Recast historical data presents continuing operations only, excluding the spun-off Biosciences and Diagnostic Solutions business.
- Spin-off completed Feb 9, 2026, with the business combined into Waters Corporation.
- Non-GAAP financial measures are included in Exhibit 99.1 to assist investor analysis.
- Recast provides a baseline for BD's standalone operating results from continuing operations.

## SEC filing metadata
- accession: 0001628280-26-023185
- form_type: 8-K
- ticker: BDX
- cik: 0000010795
- company_name: BECTON DICKINSON & CO
- filed_at: 2026-04-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/10795/000162828026023185/0001628280-26-023185-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/10795/000162828026023185/bdx-20260402.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-023185
- JSON: https://secwatch.observer/filing/0001628280-26-023185.json
- Plain text: https://secwatch.observer/filing/0001628280-26-023185.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.